Dear Dr. Nelson:
"The Endocrine Society appreciates the opportunity to provide comments on a strategic plan for Federal coordination of PFAS research and development. Founded in 1916, the Endocrine Society is the world’s oldest, largest, and most active organization of scientists and healthcare professionals dedicated to research on hormones and the clinical treatment of patients with endocrine diseases. Our membership includes 18,000 clinicians and scientists from over 120 countries, including many researchers engaged in the study of the adverse effects of per- and polyfluoroalkyl substances (PFAS) on endocrine systems. While we appreciate that the Office of Science and Technology Policy (OSTP) is interested in research gaps and opportunities, we note there already is ample evidence of harm to a variety of endocrine organs and systems due to PFAS exposure. We therefore encourage OSTP to focus research and development priorities towards knowledge gaps and solutions that will reduce further harm to individuals and communities. Below we identify several pressing challenges that should be addressed by the plan and propose solutions that would help overcome these issues."
Read the Full Letter